Literature DB >> 35488145

Research progress on the relationship between IS and kidney disease and its complications.

Yan Gao1,2,3, Ye Li1,2, Xueting Duan1,2, Qian Wang4,5,6, Haisong Zhang7,8,9.   

Abstract

Indoxyl sulphate (IS) a representative uraemic toxin in the blood of patients with chronic kidney disease (CKD). Its accumulation may be closely related to CKD and the increasing morbidity and mortality of the disease's related complications. Timely and effective detection of the IS level and efficient clearance of IS may effectively prevent the progression of CKD and its related complications. Therefore, this article summarizes the research progress of IS related, including IS in CKD and its associated complications including chronic kidney disease, chronic kidney disease with cardiovascular disease, renal anemia, bone mineral metabolic disease and neuropsychiatric disorders, looking for IS accurate rapid detection methods, and explore the efficient treatment to reduce blood levels of indole phenol sulphate.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Chronic kidney disease; Complication; Indoxyl sulphate; Research progress

Mesh:

Substances:

Year:  2022        PMID: 35488145     DOI: 10.1007/s11255-022-03209-1

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.266


  75 in total

1.  Indoxyl sulfate associates with cardiovascular phenotype in children with chronic kidney disease.

Authors:  Johannes Holle; Uwe Querfeld; Marietta Kirchner; Alexandros Anninos; Jürgen Okun; Daniela Thurn-Valsassina; Aysun Bayazit; Ana Niemirska; Nur Canpolat; Ipek Kaplan Bulut; Ali Duzova; Ali Anarat; Rukshana Shroff; Yelda Bilginer; Salim Caliskan; Cengiz Candan; Jerome Harambat; Zeynep Birsin Özcakar; Oguz Soylemezoglu; Sibylle Tschumi; Sandra Habbig; Ebru Yilmaz; Ayse Balat; Aleksandra Zurowska; Nilgun Cakar; Birgitta Kranz; Pelin Ertan; Anette Melk; Karolis Azukaitis; Franz Schaefer
Journal:  Pediatr Nephrol       Date:  2019-08-19       Impact factor: 3.714

Review 2.  The ascending rank of chronic kidney disease in the global burden of disease study.

Authors:  Kitty J Jager; Simon D S Fraser
Journal:  Nephrol Dial Transplant       Date:  2017-04-01       Impact factor: 5.992

3.  Serum Concentration of Indoxyl Sulfate in Peritoneal Dialysis Patients and Low-Flux Hemodialysis Patients.

Authors:  Ting Xie; Manchen Bao; Pan Zhang; Xiaoyan Jiao; Jianzhou Zou; Xiaoqiang Ding; Xuesen Cao; Xiaofang Yu
Journal:  Blood Purif       Date:  2019-04-30       Impact factor: 2.614

4.  Handling of Drugs, Metabolites, and Uremic Toxins by Kidney Proximal Tubule Drug Transporters.

Authors:  Sanjay K Nigam; Wei Wu; Kevin T Bush; Melanie P Hoenig; Roland C Blantz; Vibha Bhatnagar
Journal:  Clin J Am Soc Nephrol       Date:  2015-10-21       Impact factor: 8.237

Review 5.  Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-Analysis.

Authors:  Nathan R Hill; Samuel T Fatoba; Jason L Oke; Jennifer A Hirst; Christopher A O'Callaghan; Daniel S Lasserson; F D Richard Hobbs
Journal:  PLoS One       Date:  2016-07-06       Impact factor: 3.240

6.  Prevalence and risk factors of chronic kidney disease and diabetic kidney disease in Chinese rural residents: a cross-sectional survey.

Authors:  Jiayu Duan; Chongjian Wang; Dongwei Liu; Yingjin Qiao; Shaokang Pan; Dengke Jiang; Zihao Zhao; Lulu Liang; Fei Tian; Pei Yu; Yu Zhang; Huanhuan Zhao; Zhangsuo Liu
Journal:  Sci Rep       Date:  2019-07-18       Impact factor: 4.379

7.  Numerous protein-bound solutes are cleared by the kidney with high efficiency.

Authors:  Tammy L Sirich; Pavel A Aronov; Natalie S Plummer; Thomas H Hostetter; Timothy W Meyer
Journal:  Kidney Int       Date:  2013-05-01       Impact factor: 10.612

8.  Protein-Bound Uremic Toxin Profiling as a Tool to Optimize Hemodialysis.

Authors:  Sunny Eloot; Daniel Schneditz; Tom Cornelis; Wim Van Biesen; Griet Glorieux; Annemie Dhondt; Jeroen Kooman; Raymond Vanholder
Journal:  PLoS One       Date:  2016-01-22       Impact factor: 3.240

9.  Mortality risk of chronic kidney disease: A comparison between the adult populations in urban China and the United States.

Authors:  Jinwei Wang; Fang Wang; Rajiv Saran; Zhi He; Ming-Hui Zhao; Yi Li; Luxia Zhang; Jennifer Bragg-Gresham
Journal:  PLoS One       Date:  2018-03-15       Impact factor: 3.240

10.  Changing epidemiology of chronic kidney disease as a result of type 2 diabetes mellitus from 1990 to 2017: Estimates from Global Burden of Disease 2017.

Authors:  Huixian Li; Wanhong Lu; Ani Wang; Hongli Jiang; Jun Lyu
Journal:  J Diabetes Investig       Date:  2020-08-17       Impact factor: 4.232

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.